Australian Rare Disease Registry Audit: Project Update – August to October
Limited data about rare diseases related to incidence and prevalence, natural history, epidemiology, impact, and treatment outcomes or a lack thereof, is driving a global emphasis...
Rare Metabolic Disease Workforce Study – September 2021 Activity Update
‘Sustainable systems and workforce’ is one of three foundation principles of the National Strategic Action Plan for Rare Diseases (the Action Plan)...
Australian Government Announces Five Year Strategic Agreements with the Medicines Industry
On 7 September 2021, the Australian Government announced two new Strategic Agreements with Medicines Australia and the Generic and Biosimilar Medicines Association...